- 2020
- Press releases - 18.02.2020
Diabetes: the Gut Flora Yields Its Secrets for the Development of New Treatments
An organic compound produced by the gut flora – the metabolite 4-Cresol – is considered to have protective effects against both type 1 and 2 diabetes, notably by stimulating the growth of the insulin-producing pancreatic beta cells. This is according to a new study led by Inserm researcher Dominique Gauguier. These findings open up new therapeutic avenues which could improve the situation of millions of patients.
- Press releases - 13.02.2020
PTSD: Resilience after trauma: the role of memory suppression
The terrorist attacks committed in Paris and Saint-Denis on November 13, 2015 have left lasting marks, not only on the survivors and their loved ones, but also on French society as a whole. A vast transdisciplinary research program, the 13-Novembre project, seeks to understand the ongoing construction and evolution of the individual and collective memory of these traumatic events and improve our understanding of the factors that protect people against the development of post-traumatic stress disorder (PTSD).
- Press releases - 06.02.2020
Human Textiles to Repair Blood Vessels
The leading cause of mortality worldwide, cardiovascular diseases claim over 17 million lives each year, according to World Health Organization estimates. To open up new research avenues into this serious public health problem, Inserm researcher Nicolas L’Heureux and his team are developing “human textiles” from collagen in order to repair damaged blood vessels.
- Press releases - 05.02.2020
Malaria: Vaccine clinical trial for Pregnant Women yields promising results
Malaria infection during pregnancy represents a major public health problem in the regions endemic for the disease, substantially increasing the risks to mothers and their unborn children. For newborns, malaria is linked to low birth weight and an excess risk of mortality. To protect this population, a team of researchers is developing a vaccine at the French National Institute of Blood Transfusion (INTS).
- Press releases - 24.01.2020
Coronavirus: A Model Estimating Importation Risk to Europe
An Inserm team led by researcher Vittoria Colizza at Pierre Louis Institute of Epidemiology and Public Health (Inserm/Sorbonne Université) has modeled the potential spread of 2019-nCoV in order to orient prevention and surveillance policies. A model which comes with one caveat: derived from research, its purpose is not to make predictions but rather be used as a theoretical tool to aid public decision-making.
- Press releases - 20.01.2020
Deadly outbreak in China linked to a novel form of coronavirus
Deadly outbreak in China linked to a novel form of coronavirus
- What's on? - 20.01.2020
Deadly outbreak in China linked to a novel form of coronavirus
Inserm is a signatory to the following international joint statement issued by the Wellcome Trust [1] : Coronaviruses, which are named after the crown shape of the proteins that surround them, are a family of viruses that have a traditionally animal reservoir. In some cases, transmission from animal to human is possible, as […]
- Press releases - 20.01.2020
A New Blood Component Revealed
Does the blood we thought to know so well contain elements that had been undetectable until now? The answer is yes, according to a team of researchers which has revealed the presence of whole functional mitochondria in the blood circulation. These organelles that are responsible for cellular respiration had hitherto only been found outside cells in very specific cases.
- Press releases - 15.01.2020
Meningeal Lymphatic Network: A New Avenue in the Treatment of Brain Tumors
Glioblastomas are the most common type of brain tumor, and their prognosis is often highly unfavorable. A collaborative study by Jean-Léon Thomas, Inserm researcher at the Brain & Spine Institute (Inserm/CNRS/Sorbonne Université) and Pitié-Salpêtrière Hospital AP-HP, and Akiko Iwasaki (Department of Immunology, Yale University School of Medicine, USA), has revealed the beneficial role played by the meningeal lymphatic vascular network in treating these tumors – in the short and longer term.
- Press releases - 15.01.2020
B Cells: New Allies in Sarcoma Immunotherapy?
An international team led by Wolf Hervé Fridman with researchers from Inserm, Sorbonne Université and Université de Paris at the Cordeliers Research Center, in collaboration with the French League against cancer and Institut Bergonié, has shown that B cells also play a major role in predicting of patient’s response to immunotherapy. It was previously thought only T cells could be used in this way.